Published in Law and Health Weekly, September 24th, 2005
In addition to Adiana's current investors, OrbiMed Advisors LLC participated as a new investor. The company also announced that Joan P. Neuscheler of Tullis-Dickerson and Jonathan T. Silverstein, JD, of OrbiMed will join its board of directors.
"These funds will allow us to complete our clinical trial, obtain regulatory approval, and prepare for market launch next year," said Paul Goeld, Adiana's president and CEO. "We are particularly excited by the investments from Tullis-Dickerson and OrbiMed, world-class...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.